VR Logo

OncoSec Medical Incorporated (ONCS) download report


Healthcare | Biotechnology & Pharma Research

OncoSec Medical Incorporated (ONCS) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer.

IPO Date: 31-Mar-2011

VP of Fin. and Principal Accounting Officer & Controller: Mr. Robert J. DelAversano CPA

Pres & CEO: Dr. Robert H. Arch Ph.D.

Listing: NASDAQ: ONCS

Country: United States

Headquarters: Pennington, NJ

Website: https://oncosec.com

Key Facts

Market cap: $30.97 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-37.76 Mln

Cash: $19.48 Mln

Total Debt: $5.49 Mln

Insider's Holding: 56.11%

Liquidity: Low

52 Week range: $0.67 - 4.25

Shares outstanding: 39,365,500

10 Years Aggregate:

  • CFO: $-198.70 Mln
  • EBITDA: $-245.96 Mln
  • Net Profit: $-247.94 Mln

Stock Performance

Time Period OncoSec Medical (ONCS) S&P BSE Sensex* S&P Small-Cap 600*
YTD-18.04-8.74-17.60
1 month-7.44-2.01-5.38
3 months-32.17-7.32-13.22
1 Year-76.790.45-16.83
3 Years-33.4510.327.77
5 Years-40.6711.296.21
10 Years-33.1912.1410.48
As on 24-Jun-2022 *As on 27-Jun-2022
Year OncoSec Medical (ONCS) S&P Small-Cap 600 S&P BSE Sensex
2021-85.1225.2721.99
2020256.359.5715.75
2019-71.7220.8614.38
2018-60.41-9.705.87
201732.1111.7327.91
2016-48.1024.741.95
2015-74.79-3.36-5.03